drugset / Trial / NCT05080010
Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effect of 3 cycles of chemotherapy(CEV) in the treatment of Stage I enucleated retinoblastoma.
Timeline
- Start
- 2020-11-01
- Primary completion
- 2030-12-31
- Completion
- 2030-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 560 mg/m2 | — |
| Subject | Etoposide | Small molecule | 150 mg/m2 | — |
| Subject | Vincristine | Small molecule | 1.5 mg/m2 | — |